Stage IA Breast Cancer Recruiting Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs